


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+132.44%
-1.04%
+1.81%
-2.69%
-7.93%
CME
CME Group
$273.08
Strengths

Trading below its fair value

Earnings are forecast to grow

Outperform the market

Investors confidence is positive
Technical Indicators

MACD below signal line

Aroon crosses up
CME Price Performance
$273.19 (-0.04%)
$263.65 (+3.58%)
$285.75 (-4.43%)
$232.71 (+17.35%)
CME has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

CME overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Revenue declined YoY

Earnings decline YoY
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Trading below its fair value

Earnings are forecast to grow

Outperform the market
![]()
CME Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CME Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
What is CME current stock price?
What are CME stock strengths?
What is CME Risk Level?
What is CME market cap and volume?
What is CME current Stock IQ?
Should I buy CME stock right now?
Is CME a Strong Buy right now?
What does a 'Strong Buy' rating mean for CME?
What does a 'Strong Sell' rating mean for CME?
What factors influence CME's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+132.44%
-1.04%
+1.81%
-2.69%
-7.93%
CME
CME Group
Current Price
$273.08
Stock Insights
Strengths

Trading below its fair value

Earnings are forecast to grow

Outperform the market

Investors confidence is positive
Technical Indicators

MACD below signal line

Aroon crosses up

CME Price Performance
$273.19 (-0.04%)
$263.65 (+3.58%)
$285.75 (-4.43%)
$232.71 (+17.35%)
CME Analysts Opinion
CME Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Revenue declined YoY

Earnings decline YoY
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Trading below its fair value

Earnings are forecast to grow

Outperform the market
![]()
CME Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CME Street Sentiment is extremely bullish and have positive views on the near-term outlook
CME has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
CME Stock IQ
CME Latest Analysis
Morgan Stanley Maintains CME Group (CME) Overweight Recommendation. Fintel reports that on December 22 2025 Morgan Stanley maintained coverage of CME Group (NasdaqGS:CME) with a Overweight recommendation. Analyst Price Forecast Suggests 6.76% Upside
Tue Dec 23, 2025
FanDuel and CME Group Launch FanDuel Predicts to Give Customers the Power to Trade on Tomorrows Headlines. New prediction markets platform launches in five states with a phased expansion to other states through early 2026 NEW YORK AND CHICAGO Dec. 22 2025 /PRNewswire/ -- Today FanDuel the premier online gaming company in North America and part of Flutter Entertainment (NYSE: FLUT LSE:...
Mon Dec 22, 2025
FanDuel CME Group launch prediction markets in five US states.
Mon Dec 22, 2025
CME Outperforms Industry Trades at a Discount: Time to Hold?. CME Group remains poised for growth riding on solid global presence a compelling product portfolio increased electronic trading and a focus on over-the-counter clearing services.
Thu Dec 18, 2025
Magellan Global Funds Thoughts on CME Group (CME). Magellan Asset Management an investment management company released the third quarter 2025 investor letter for Magellan Global Fund. A copy of the letter can be downloaded here. The fund focuses on outstanding companies at attractive prices and at the same time leverages a deep understanding of the macroeconomic landscape to manage risk. As measured by [….]
Tue Dec 16, 2025
CME Group to Launch Spot-ed XRP and SOL Futures. CHICAGO Dec. 15 2025 /PRNewswire/ -- CME Group the worlds leading derivatives marketplace today launched Spot-ed XRP and SOL futures. Spot-ed XRP and SOL futures will complement the existing Spot-ed Bitcoin and Ether futures and are also available to trade across the...
Mon Dec 15, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.